Mechanistically, escin activates hippocampal miR-223 expression, resulting in inhibition of the NF‐κB pathway but enhancement of BDNF/TrkB pathway activity, thereby reducing neuroinflammation and counteracting depression‐associated neuropathology [29, 55]. Here, NTRK2 is linked to depressive disorder.